CN Stock MarketDetailed Quotes

300357 Zhejiang Wolwo Bio-Pharmaceutical

Watchlist
  • 25.55
  • +0.77+3.11%
Market Closed May 20 15:00 CST
13.38BMarket Cap42.23P/E (TTM)

Zhejiang Wolwo Bio-Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
18.08%216.25M
-5.34%848.19M
-3.77%673.79M
-0.67%386.3M
-7.31%183.14M
10.94%896.02M
12.98%700.18M
11.88%388.9M
20.00%197.59M
26.95%807.69M
Operating revenue
18.08%216.25M
-5.34%848.19M
-3.77%673.79M
-0.67%386.3M
-7.31%183.14M
10.94%896.02M
12.98%700.18M
11.88%388.9M
20.00%197.59M
26.95%807.69M
Other operating revenue
----
554.82%7.44M
----
-55.85%251.51K
----
-68.23%1.14M
----
-40.00%569.7K
----
28.19%3.58M
Total operating cost
19.37%132.39M
5.48%513.94M
5.30%373.88M
9.67%230.62M
2.59%110.91M
11.25%487.24M
13.44%355.06M
9.08%210.29M
13.45%108.11M
31.50%437.96M
Operating cost
8.24%10.42M
-2.64%40.19M
1.14%30.96M
17.93%19.48M
17.47%9.62M
19.86%41.28M
20.07%30.61M
9.55%16.52M
17.75%8.19M
20.68%34.44M
Operating tax surcharges
47.54%1.29M
26.96%5.76M
2.71%3.19M
11.74%2.16M
12.34%876.35K
19.98%4.53M
17.16%3.1M
14.22%1.94M
30.24%780.1K
15.69%3.78M
Operating expense
16.25%80.96M
3.64%323.17M
6.42%242.62M
9.48%147.29M
3.85%69.64M
10.53%311.81M
10.95%227.99M
6.33%134.54M
9.73%67.06M
26.14%282.11M
Administration expense
28.53%16.46M
29.87%62.11M
17.02%40.63M
28.36%26.23M
17.56%12.8M
-7.78%47.82M
-1.49%34.72M
-7.31%20.43M
-5.62%10.89M
44.40%51.86M
Financial expense
-13.23%-7.3M
-21.70%-29.48M
-24.46%-22.02M
-19.77%-14.13M
-13.77%-6.45M
-9.37%-24.23M
-5.31%-17.69M
-4.29%-11.8M
-11.77%-5.67M
4.51%-22.15M
-Interest expense (Financial expense)
19.02%319.26K
194.70%1.31M
267.75%915.71K
354.48%658.57K
235.20%268.23K
22.57%443.98K
-9.31%249.01K
-25.62%144.91K
-22.00%80.02K
--362.22K
-Interest Income (Financial expense)
-15.15%-7.76M
-24.96%-30.96M
-27.77%-23.03M
-23.74%-14.85M
-16.68%-6.74M
-9.42%-24.77M
-4.99%-18.03M
-3.72%-12M
-11.05%-5.78M
2.85%-22.64M
Research and development
25.19%30.56M
5.83%112.2M
2.85%78.49M
1.90%49.59M
-9.08%24.41M
20.58%106.02M
25.31%76.32M
25.60%48.67M
33.25%26.85M
35.53%87.93M
Credit Impairment Loss
-2,967.77%-1.88M
169.98%903.31K
29.13%-2.95M
109.20%78.07K
109.88%65.63K
19.07%-1.29M
2.75%-4.16M
54.71%-848.48K
13.76%-664.45K
-329.82%-1.59M
Asset Impairment Loss
----
98.94%-472.55K
---472.55K
---472.55K
----
---44.4M
----
----
----
----
Other net revenue
79.17%4.15M
185.28%10.72M
-97.83%676.75K
-85.79%4.04M
-85.05%2.31M
-154.23%-12.57M
155.46%31.25M
121.35%28.42M
33.46%15.47M
26.22%23.18M
Fair value change income
140.75%400.18K
24.25%-666.94K
-251.92%-1.57M
-272.34%-1.21M
-149.61%-982.13K
-783.37%-880.46K
-73.21%1.04M
-115.66%-325.52K
205.78%1.98M
-103.74%-99.67K
Invest income
-114.74%-363.77K
-46.56%1.91M
-49.43%2.36M
-34.17%3.21M
265.97%2.47M
-44.03%3.58M
193.09%4.67M
186.04%4.88M
-83.28%674.44K
382.32%6.39M
-Including: Investment income associates
44.73%-434.53K
14.06%-4.25M
-49.08%-3.8M
-65.60%-1.94M
-158.53%-786.13K
-159.16%-4.95M
-1,044.38%-2.55M
---1.17M
---304.08K
---1.91M
Asset deal income
--284.61K
----
----
----
----
---271.92K
---271.92K
---271.92K
---278.78K
----
Other revenue
649.12%5.71M
-70.54%9.04M
-88.96%3.31M
-90.27%2.43M
-94.46%761.72K
66.12%30.7M
171.22%29.98M
128.65%24.99M
34.89%13.76M
25.34%18.48M
Operating profit
18.06%88.01M
-12.93%344.97M
-20.14%300.59M
-22.86%159.71M
-28.97%74.54M
0.84%396.21M
18.00%376.37M
23.48%207.03M
29.63%104.95M
22.20%392.91M
Add:Non operating Income
-25.58%117.42K
-35.02%1.78M
-52.61%1.06M
-44.11%988.72K
-87.35%157.78K
340.72%2.74M
-9.93%2.23M
-9.16%1.77M
14,153.97%1.25M
-71.43%620.83K
Less:Non operating expense
5,587.52%327.4K
306.44%795.74K
113.03%180.72K
27.60%100.62K
-92.70%5.76K
-62.96%195.78K
-81.74%84.83K
-9.97%78.85K
-9.58%78.81K
-50.85%528.53K
Total profit
17.54%87.8M
-13.24%345.96M
-20.36%301.46M
-23.06%160.6M
-29.61%74.7M
1.46%398.75M
17.93%378.52M
23.12%208.72M
31.21%106.12M
21.82%393M
Less:Income tax cost
80.84%13.88M
-19.98%50.43M
-30.06%41.68M
-41.85%18.89M
-55.25%7.67M
-5.53%63.02M
9.01%59.6M
18.41%32.48M
30.38%17.15M
26.12%66.71M
Net profit
10.29%73.92M
-11.97%295.52M
-18.54%259.78M
-19.59%141.71M
-24.67%67.02M
2.89%335.73M
19.76%318.92M
24.03%176.24M
31.36%88.97M
20.97%326.29M
Net profit from continuing operation
10.29%73.92M
-11.97%295.52M
-18.54%259.78M
-19.59%141.71M
-24.67%67.02M
2.89%335.73M
19.76%318.92M
24.03%176.24M
31.36%88.97M
20.97%326.29M
Less:Minority Profit
4.81%-3.29M
-12.37%-14.66M
-24.91%-10.37M
-42.43%-6.89M
-25.00%-3.46M
-11.50%-13.05M
-0.00%-8.3M
7.33%-4.84M
-1.43%-2.77M
-34.16%-11.7M
Net profit of parent company owners
9.55%77.21M
-11.06%310.18M
-17.44%270.15M
-17.93%148.6M
-23.17%70.48M
3.19%348.77M
19.16%327.22M
22.92%181.08M
30.21%91.74M
21.38%337.99M
Earning per share
Basic earning per share
9.58%0.1475
-11.06%0.5924
-17.44%0.516
-17.93%0.2838
-23.17%0.1346
3.19%0.6661
19.18%0.625
22.89%0.3458
30.16%0.1752
21.38%0.6455
Diluted earning per share
9.58%0.1475
-11.06%0.5924
-17.44%0.516
-17.93%0.2838
-23.17%0.1346
3.19%0.6661
19.18%0.625
22.89%0.3458
30.16%0.1752
21.38%0.6455
Other composite income
89,860.06%5.35M
-83.40%4.32K
-72.65%8.11K
-25.55%9.56K
-164.54%-5.96K
-99.90%26.03K
1,087.55%29.66K
483.80%12.84K
-282.10%-2.25K
3,550.24%25.94M
Other composite income of parent company owners
89,860.06%5.35M
-83.40%4.32K
-72.65%8.11K
-25.55%9.56K
-164.54%-5.96K
-99.90%26.03K
1,087.55%29.66K
483.80%12.84K
-282.10%-2.25K
3,550.24%25.94M
Total composite income
18.28%79.26M
-11.98%295.53M
-18.55%259.79M
-19.59%141.72M
-24.67%67.01M
-4.68%335.75M
19.77%318.95M
24.04%176.26M
31.36%88.97M
30.25%352.23M
Total composite income of parent company owners
17.15%82.56M
-11.07%310.19M
-17.45%270.16M
-17.94%148.61M
-23.18%70.47M
-4.16%348.8M
19.18%327.25M
22.93%181.09M
30.20%91.73M
30.37%363.93M
Total composite income of minority owners
4.81%-3.29M
-12.37%-14.66M
-24.91%-10.37M
-42.43%-6.89M
-25.00%-3.46M
-11.50%-13.05M
-0.00%-8.3M
7.33%-4.84M
-1.43%-2.77M
-34.16%-11.7M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
--
--
--
Ernst & Young (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 18.08%216.25M-5.34%848.19M-3.77%673.79M-0.67%386.3M-7.31%183.14M10.94%896.02M12.98%700.18M11.88%388.9M20.00%197.59M26.95%807.69M
Operating revenue 18.08%216.25M-5.34%848.19M-3.77%673.79M-0.67%386.3M-7.31%183.14M10.94%896.02M12.98%700.18M11.88%388.9M20.00%197.59M26.95%807.69M
Other operating revenue ----554.82%7.44M-----55.85%251.51K-----68.23%1.14M-----40.00%569.7K----28.19%3.58M
Total operating cost 19.37%132.39M5.48%513.94M5.30%373.88M9.67%230.62M2.59%110.91M11.25%487.24M13.44%355.06M9.08%210.29M13.45%108.11M31.50%437.96M
Operating cost 8.24%10.42M-2.64%40.19M1.14%30.96M17.93%19.48M17.47%9.62M19.86%41.28M20.07%30.61M9.55%16.52M17.75%8.19M20.68%34.44M
Operating tax surcharges 47.54%1.29M26.96%5.76M2.71%3.19M11.74%2.16M12.34%876.35K19.98%4.53M17.16%3.1M14.22%1.94M30.24%780.1K15.69%3.78M
Operating expense 16.25%80.96M3.64%323.17M6.42%242.62M9.48%147.29M3.85%69.64M10.53%311.81M10.95%227.99M6.33%134.54M9.73%67.06M26.14%282.11M
Administration expense 28.53%16.46M29.87%62.11M17.02%40.63M28.36%26.23M17.56%12.8M-7.78%47.82M-1.49%34.72M-7.31%20.43M-5.62%10.89M44.40%51.86M
Financial expense -13.23%-7.3M-21.70%-29.48M-24.46%-22.02M-19.77%-14.13M-13.77%-6.45M-9.37%-24.23M-5.31%-17.69M-4.29%-11.8M-11.77%-5.67M4.51%-22.15M
-Interest expense (Financial expense) 19.02%319.26K194.70%1.31M267.75%915.71K354.48%658.57K235.20%268.23K22.57%443.98K-9.31%249.01K-25.62%144.91K-22.00%80.02K--362.22K
-Interest Income (Financial expense) -15.15%-7.76M-24.96%-30.96M-27.77%-23.03M-23.74%-14.85M-16.68%-6.74M-9.42%-24.77M-4.99%-18.03M-3.72%-12M-11.05%-5.78M2.85%-22.64M
Research and development 25.19%30.56M5.83%112.2M2.85%78.49M1.90%49.59M-9.08%24.41M20.58%106.02M25.31%76.32M25.60%48.67M33.25%26.85M35.53%87.93M
Credit Impairment Loss -2,967.77%-1.88M169.98%903.31K29.13%-2.95M109.20%78.07K109.88%65.63K19.07%-1.29M2.75%-4.16M54.71%-848.48K13.76%-664.45K-329.82%-1.59M
Asset Impairment Loss ----98.94%-472.55K---472.55K---472.55K-------44.4M----------------
Other net revenue 79.17%4.15M185.28%10.72M-97.83%676.75K-85.79%4.04M-85.05%2.31M-154.23%-12.57M155.46%31.25M121.35%28.42M33.46%15.47M26.22%23.18M
Fair value change income 140.75%400.18K24.25%-666.94K-251.92%-1.57M-272.34%-1.21M-149.61%-982.13K-783.37%-880.46K-73.21%1.04M-115.66%-325.52K205.78%1.98M-103.74%-99.67K
Invest income -114.74%-363.77K-46.56%1.91M-49.43%2.36M-34.17%3.21M265.97%2.47M-44.03%3.58M193.09%4.67M186.04%4.88M-83.28%674.44K382.32%6.39M
-Including: Investment income associates 44.73%-434.53K14.06%-4.25M-49.08%-3.8M-65.60%-1.94M-158.53%-786.13K-159.16%-4.95M-1,044.38%-2.55M---1.17M---304.08K---1.91M
Asset deal income --284.61K-------------------271.92K---271.92K---271.92K---278.78K----
Other revenue 649.12%5.71M-70.54%9.04M-88.96%3.31M-90.27%2.43M-94.46%761.72K66.12%30.7M171.22%29.98M128.65%24.99M34.89%13.76M25.34%18.48M
Operating profit 18.06%88.01M-12.93%344.97M-20.14%300.59M-22.86%159.71M-28.97%74.54M0.84%396.21M18.00%376.37M23.48%207.03M29.63%104.95M22.20%392.91M
Add:Non operating Income -25.58%117.42K-35.02%1.78M-52.61%1.06M-44.11%988.72K-87.35%157.78K340.72%2.74M-9.93%2.23M-9.16%1.77M14,153.97%1.25M-71.43%620.83K
Less:Non operating expense 5,587.52%327.4K306.44%795.74K113.03%180.72K27.60%100.62K-92.70%5.76K-62.96%195.78K-81.74%84.83K-9.97%78.85K-9.58%78.81K-50.85%528.53K
Total profit 17.54%87.8M-13.24%345.96M-20.36%301.46M-23.06%160.6M-29.61%74.7M1.46%398.75M17.93%378.52M23.12%208.72M31.21%106.12M21.82%393M
Less:Income tax cost 80.84%13.88M-19.98%50.43M-30.06%41.68M-41.85%18.89M-55.25%7.67M-5.53%63.02M9.01%59.6M18.41%32.48M30.38%17.15M26.12%66.71M
Net profit 10.29%73.92M-11.97%295.52M-18.54%259.78M-19.59%141.71M-24.67%67.02M2.89%335.73M19.76%318.92M24.03%176.24M31.36%88.97M20.97%326.29M
Net profit from continuing operation 10.29%73.92M-11.97%295.52M-18.54%259.78M-19.59%141.71M-24.67%67.02M2.89%335.73M19.76%318.92M24.03%176.24M31.36%88.97M20.97%326.29M
Less:Minority Profit 4.81%-3.29M-12.37%-14.66M-24.91%-10.37M-42.43%-6.89M-25.00%-3.46M-11.50%-13.05M-0.00%-8.3M7.33%-4.84M-1.43%-2.77M-34.16%-11.7M
Net profit of parent company owners 9.55%77.21M-11.06%310.18M-17.44%270.15M-17.93%148.6M-23.17%70.48M3.19%348.77M19.16%327.22M22.92%181.08M30.21%91.74M21.38%337.99M
Earning per share
Basic earning per share 9.58%0.1475-11.06%0.5924-17.44%0.516-17.93%0.2838-23.17%0.13463.19%0.666119.18%0.62522.89%0.345830.16%0.175221.38%0.6455
Diluted earning per share 9.58%0.1475-11.06%0.5924-17.44%0.516-17.93%0.2838-23.17%0.13463.19%0.666119.18%0.62522.89%0.345830.16%0.175221.38%0.6455
Other composite income 89,860.06%5.35M-83.40%4.32K-72.65%8.11K-25.55%9.56K-164.54%-5.96K-99.90%26.03K1,087.55%29.66K483.80%12.84K-282.10%-2.25K3,550.24%25.94M
Other composite income of parent company owners 89,860.06%5.35M-83.40%4.32K-72.65%8.11K-25.55%9.56K-164.54%-5.96K-99.90%26.03K1,087.55%29.66K483.80%12.84K-282.10%-2.25K3,550.24%25.94M
Total composite income 18.28%79.26M-11.98%295.53M-18.55%259.79M-19.59%141.72M-24.67%67.01M-4.68%335.75M19.77%318.95M24.04%176.26M31.36%88.97M30.25%352.23M
Total composite income of parent company owners 17.15%82.56M-11.07%310.19M-17.45%270.16M-17.94%148.61M-23.18%70.47M-4.16%348.8M19.18%327.25M22.93%181.09M30.20%91.73M30.37%363.93M
Total composite income of minority owners 4.81%-3.29M-12.37%-14.66M-24.91%-10.37M-42.43%-6.89M-25.00%-3.46M-11.50%-13.05M-0.00%-8.3M7.33%-4.84M-1.43%-2.77M-34.16%-11.7M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)------Ernst & Young (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg